GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

TNF (TNFA protein) (Tumor necrosis factor) (Tumor necrosis factor (TNF superfamily, member 2)) (Tumor necrosis factor ligand 1F) (Tumor necrosis factor-alpha) (cDNA, FLJ95875, Homo sapiens tumor necrosis factor (TNF superfamily, member 2)(TNF), mRNA)

 Q5STB3_HUMAN            Unreviewed;       233 AA.
Q5STB3; E7DB75;
10-MAY-2005, integrated into UniProtKB/TrEMBL.
10-MAY-2005, sequence version 1.
13-FEB-2019, entry version 143.
SubName: Full=TNF {ECO:0000313|EMBL:AQY77148.1};
SubName: Full=TNFA protein {ECO:0000313|EMBL:BAF31279.1};
SubName: Full=Tumor necrosis factor {ECO:0000313|EMBL:AHJ25918.1};
SubName: Full=Tumor necrosis factor (TNF superfamily, member 2) {ECO:0000313|EMBL:BAE78639.1};
SubName: Full=Tumor necrosis factor ligand 1F {ECO:0000313|EMBL:CTQ86082.1};
SubName: Full=Tumor necrosis factor-alpha {ECO:0000313|EMBL:ADV31546.2};
SubName: Full=cDNA, FLJ95875, Homo sapiens tumor necrosis factor (TNF superfamily, member 2)(TNF), mRNA {ECO:0000313|EMBL:BAG37464.1};
Name=TNF {ECO:0000313|EMBL:AHJ25918.1};
Synonyms=TNFA {ECO:0000313|EMBL:BAF31279.1},
TNLG1F {ECO:0000313|EMBL:CTQ86082.1};
ORFNames=hCG_43716 {ECO:0000313|EMBL:EAX03424.1};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606 {ECO:0000313|EMBL:ADV31546.2};
[1] {ECO:0000313|EMBL:EAX03424.1}
NUCLEOTIDE SEQUENCE.
PubMed=11181995; DOI=10.1126/science.1058040;
Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
"The sequence of the human genome.";
Science 291:1304-1351(2001).
[2] {ECO:0000313|EMBL:EAX03424.1}
NUCLEOTIDE SEQUENCE.
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[3] {ECO:0000313|EMBL:BAE78639.1}
NUCLEOTIDE SEQUENCE.
TISSUE=Peripheral blood leukocyte {ECO:0000313|EMBL:BAE78639.1};
PubMed=16702430; DOI=10.1534/genetics.106.057034;
Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M.,
Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K.,
Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y.,
Meyer A., Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K.,
Gojobori T., Inoko H., Bahram S.;
"Rapid evolution of major histocompatibility complex class I genes in
primates generates new disease alleles in humans via hitchhiking
diversity.";
Genetics 173:1555-1570(2006).
[4] {ECO:0000313|EMBL:BAG37464.1}
NUCLEOTIDE SEQUENCE.
Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
Isogai T.;
"NEDO functional analysis of protein and research application
project.";
Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
[5] {ECO:0000313|EMBL:ADV31546.2}
NUCLEOTIDE SEQUENCE.
Rajmani R.S., Tiwari A.K., Subudhi P., Ravi Kumar G., Sahoo A.,
Palia S.K., Uttara C., Lovleen S., Shika S., Sangeeta T., Doley J.,
Singh P.K.;
Submitted (AUG-2010) to the EMBL/GenBank/DDBJ databases.
[6] {ECO:0000313|EMBL:ADV31546.2}
NUCLEOTIDE SEQUENCE.
Rajmani R., Tiwari A., Ravi Kumar G., Sahoo A., Doley J., Singh P.,
Rajiv K., Lovleen S., Shikha S., Chaturvedi U., Palia S., Tiwari S.;
Submitted (MAY-2011) to the EMBL/GenBank/DDBJ databases.
[7] {ECO:0000313|EMBL:AHJ25918.1}
NUCLEOTIDE SEQUENCE.
Selby S.T., Hou L., Steiner N., Hurley C.K., Posch P.E.;
"TNF and LTA diversity in Caucasians.";
Submitted (NOV-2013) to the EMBL/GenBank/DDBJ databases.
[8] {ECO:0000313|EMBL:CTQ86082.1}
NUCLEOTIDE SEQUENCE.
PubMed=26646413; DOI=10.1007/s00251-015-0887-5;
Premzl M.;
"Comparative genomic analysis of eutherian tumor necrosis factor
ligand genes.";
Immunogenetics 68:125-132(2016).
[9] {ECO:0000313|EMBL:AQY77148.1}
NUCLEOTIDE SEQUENCE.
Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
"CDS alleles of MHC region genes derived from homozygous
individuals.";
Submitted (APR-2017) to the EMBL/GenBank/DDBJ databases.
-!- SUBUNIT: Homotrimer. {ECO:0000256|SAAS:SAAS01066150}.
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS01063692}.
-!- SIMILARITY: Belongs to the tumor necrosis factor family.
{ECO:0000256|SAAS:SAAS00758062}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; HQ201306; ADV31546.2; -; mRNA.
EMBL; KF887965; AHJ25918.1; -; Genomic_DNA.
EMBL; KF887966; AHJ25919.1; -; Genomic_DNA.
EMBL; KF887967; AHJ25920.1; -; Genomic_DNA.
EMBL; KF887968; AHJ25921.1; -; Genomic_DNA.
EMBL; KF887969; AHJ25922.1; -; Genomic_DNA.
EMBL; KF887970; AHJ25923.1; -; Genomic_DNA.
EMBL; KF887971; AHJ25924.1; -; Genomic_DNA.
EMBL; KF887972; AHJ25925.1; -; Genomic_DNA.
EMBL; KY500676; AQY77148.1; -; Genomic_DNA.
EMBL; KY500678; AQY77150.1; -; Genomic_DNA.
EMBL; AB202113; BAE78639.1; -; Genomic_DNA.
EMBL; AB103618; BAF31279.1; -; Genomic_DNA.
EMBL; AK314960; BAG37464.1; -; mRNA.
EMBL; LN874317; CTQ86082.1; -; mRNA.
EMBL; CH471081; EAX03424.1; -; Genomic_DNA.
RefSeq; NP_000585.2; NM_000594.3.
UniGene; Hs.241570; -.
DNASU; 7124; -.
GeneID; 7124; -.
KEGG; hsa:7124; -.
UCSC; uc003nui.5; human.
CTD; 7124; -.
EuPathDB; HostDB:ENSG00000232810.3; -.
PharmGKB; PA435; -.
eggNOG; ENOG410ISAN; Eukaryota.
eggNOG; ENOG410YQC4; LUCA.
HOVERGEN; HBG012516; -.
KO; K03156; -.
OMA; QLQWLSR; -.
OrthoDB; 1124938at2759; -.
ChiTaRS; TNF; human.
GenomeRNAi; 7124; -.
Bgee; ENSG00000232810; Expressed in 89 organ(s), highest expression level in leukocyte.
GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0045121; C:membrane raft; IEA:Ensembl.
GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
GO; GO:0055037; C:recycling endosome; IEA:Ensembl.
GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
GO; GO:0002020; F:protease binding; IEA:Ensembl.
GO; GO:0005164; F:tumor necrosis factor receptor binding; IEA:Ensembl.
GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
GO; GO:0045123; P:cellular extravasation; IEA:Ensembl.
GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
GO; GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl.
GO; GO:0072577; P:endothelial cell apoptotic process; IEA:Ensembl.
GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
GO; GO:0006959; P:humoral immune response; IEA:Ensembl.
GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl.
GO; GO:0007254; P:JNK cascade; IEA:Ensembl.
GO; GO:0097527; P:necroptotic signaling pathway; IEA:Ensembl.
GO; GO:0010693; P:negative regulation of alkaline phosphatase activity; IEA:Ensembl.
GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl.
GO; GO:0046325; P:negative regulation of glucose import; IEA:Ensembl.
GO; GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl.
GO; GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl.
GO; GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl.
GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
GO; GO:0002876; P:positive regulation of chronic inflammatory response to antigenic stimulus; IEA:Ensembl.
GO; GO:0031622; P:positive regulation of fever generation; IEA:Ensembl.
GO; GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl.
GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IEA:Ensembl.
GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
GO; GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl.
GO; GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl.
GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IEA:Ensembl.
GO; GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0045994; P:positive regulation of translational initiation by iron; IEA:Ensembl.
GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IEA:Ensembl.
GO; GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl.
GO; GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl.
GO; GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl.
GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IEA:Ensembl.
GO; GO:0050807; P:regulation of synapse organization; IEA:Ensembl.
GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl.
CDD; cd00184; TNF; 1.
Gene3D; 2.60.120.40; -; 1.
InterPro; IPR006053; TNF.
InterPro; IPR002959; TNF_alpha.
InterPro; IPR021184; TNF_CS.
InterPro; IPR006052; TNF_dom.
InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
PANTHER; PTHR11471:SF23; PTHR11471:SF23; 1.
Pfam; PF00229; TNF; 1.
PRINTS; PR01234; TNECROSISFCT.
PRINTS; PR01235; TNFALPHA.
SMART; SM00207; TNF; 1.
SUPFAM; SSF49842; SSF49842; 1.
PROSITE; PS00251; TNF_1; 1.
PROSITE; PS50049; TNF_2; 1.
2: Evidence at transcript level;
Cytokine {ECO:0000256|SAAS:SAAS00562264};
Membrane {ECO:0000256|SAAS:SAAS01066085, ECO:0000256|SAM:Phobius};
Secreted {ECO:0000256|SAAS:SAAS01063664};
Transmembrane {ECO:0000256|SAAS:SAAS01066085,
ECO:0000256|SAM:Phobius};
Transmembrane helix {ECO:0000256|SAAS:SAAS01066085,
ECO:0000256|SAM:Phobius}.
TRANSMEM 30 55 Helical. {ECO:0000256|SAM:Phobius}.
DOMAIN 89 233 TNF_2. {ECO:0000259|PROSITE:PS50049}.
SEQUENCE 233 AA; 25644 MW; 3DF90F96C9031FFE CRC64;
MSTESMIRDV ELAEEALPKK TGGPQGSRRC LFLSLFSFLI VAGATTLFCL LHFGVIGPQR
EEFPRDLSLI SPLAQAVRSS SRTPSDKPVA HVVANPQAEG QLQWLNRRAN ALLANGVELR
DNQLVVPSEG LYLIYSQVLF KGQGCPSTHV LLTHTISRIA VSYQTKVNLL SAIKSPCQRE
TPEGAEAKPW YEPIYLGGVF QLEKGDRLSA EINRPDYLDF AESGQVYFGI IAL


Related products :

Catalog number Product name Quantity
E0133h ELISA Cachectin,Homo sapiens,Human,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133h ELISA kit Cachectin,Homo sapiens,Human,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133h CLIA Cachectin,Homo sapiens,Human,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 1 mg
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 0.5 mg
E0133p ELISA Cachectin,Pig,Sus scrofa,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133p ELISA kit Cachectin,Pig,Sus scrofa,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133p CLIA Cachectin,Pig,Sus scrofa,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133r CLIA Cachectin,Rat,Rattus norvegicus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133m ELISA kit Cachectin,Mouse,Mus musculus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133b CLIA Bos taurus,Bovine,Cachectin,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133m ELISA Cachectin,Mouse,Mus musculus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133b ELISA kit Bos taurus,Bovine,Cachectin,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133r ELISA kit Cachectin,Rat,Rattus norvegicus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133m CLIA Cachectin,Mouse,Mus musculus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133b ELISA Bos taurus,Bovine,Cachectin,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133r ELISA Cachectin,Rat,Rattus norvegicus,Tnf,Tnfa,TNF-a,TNF-alpha,Tnfsf2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0133Rb CLIA Cachectin,Oryctolagus cuniculus,Rabbit,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133Rb ELISA Cachectin,Oryctolagus cuniculus,Rabbit,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
E0133Rb ELISA kit Cachectin,Oryctolagus cuniculus,Rabbit,TNF,TNFA,TNF-a,TNF-alpha,TNFSF2,Tumor necrosis factor,Tumor necrosis factor ligand superfamily member 2 96T
U0132h CLIA Homo sapiens,Human,p75,p80 TNF-alpha receptor,TNFBR,TNFR2,TNF-R2,TNF-RII,TNFR-II,TNFRSF1B,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis fact 96T
E0132h ELISA Homo sapiens,Human,p75,p80 TNF-alpha receptor,TNFBR,TNFR2,TNF-R2,TNF-RII,TNFR-II,TNFRSF1B,Tumor necrosis factor receptor 2,Tumor necrosis factor receptor superfamily member 1B,Tumor necrosis fac 96T
E0131h ELISA Homo sapiens,Human,p55,p60,TNFAR,TNFR1,TNF-R1,TNF-RI,TNFR-I,TNFRSF1A,Tumor necrosis factor receptor 1,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor type I 96T
U0131h CLIA Homo sapiens,Human,p55,p60,TNFAR,TNFR1,TNF-R1,TNF-RI,TNFR-I,TNFRSF1A,Tumor necrosis factor receptor 1,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor type I 96T
E0131h ELISA kit Homo sapiens,Human,p55,p60,TNFAR,TNFR1,TNF-R1,TNF-RI,TNFR-I,TNFRSF1A,Tumor necrosis factor receptor 1,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor typ 96T

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP1899: Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs)
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP1983: Splicing factor NOVA regulated synpatic proteins
WP2148: Brain derived neurotrophic factor
WP2249: Metastatic brain tumor
WP272: Blood Clotting Cascade
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP444: Signaling of Hepatocyte Growth Factor Receptor
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP94: Signaling of Hepatocyte Growth Factor Receptor
WP1834: Interactions of the immunoglobulin superfamily (IgSF) member proteins
WP1487: TNF-alpha and mucus production in lung epythelium
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP210: Cytoplasmic Ribosomal Proteins
WP2199: Seed Development
WP2218: sGC
WP1003: Ovarian Infertility Genes
WP1023: mRNA processing

Related Genes :
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738] Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNFSF11 OPGL RANKL TRANCE] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Tnfsf11 Opgl Rankl Trance] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]

Bibliography :